Literature DB >> 9833977

The ultrastructural characteristics of eccrine sweat glands in a Fabry disease patient with hypohidrosis.

L M Lao1, M Kumakiri, H Mima, H Kuwahara, H Ishida, K Ishiguro, T Fujita, K Ueda.   

Abstract

As an investigation of the pathogenetic mechanism of diminished sweating in Fabry disease, an electron microscopy ultrastructural study was conducted on specimens of eccrine sweat glands from a typical patient with Fabry disease who had hypohidrosis, a low skin moisture content, and diminished thermoregulation ability. Numerous characteristic cytoplasmic inclusions were observed in the eccrine sweat glands, the lamellar pattern of which was considerably variable in various types of gland cells. Large vacuolar inclusions predominated in clear cells of secretory coil; lesser vacuoles were also seen in the coiled duct, and the basal cells of the straight duct toward the coiled duct displayed mulberry-like figures. There were some clear cells showing cell damage and necrosis in the secretory coil. Lamellated inclusions were noted in the unmyelinated axons innervating the eccrine sweat glands. The small blood vessels around the eccrine glands were narrowed by swollen endothelial cells with heavy inclusions. These intracytoplasmic deposits may be responsible for the decreased sweating ability in Fabry disease. The factors related to hypohidrosis are also discussed.

Entities:  

Mesh:

Year:  1998        PMID: 9833977     DOI: 10.1016/s0923-1811(98)00032-2

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  9 in total

1.  Generalized anhidrosis with preganglionic sudomotor dysfunction in Fabry disease: a case report.

Authors:  Eun Bin Cho; Seung Joo Kim; Tae-Won Yang; Heejeong Jeong; Changhyo Yoon; Seunguk Jung; Ki-Jong Park
Journal:  Clin Auton Res       Date:  2021-04-10       Impact factor: 4.435

Review 2.  Fabry disease-often seen, rarely diagnosed.

Authors:  Björn Hoffmann; Ertan Mayatepek
Journal:  Dtsch Arztebl Int       Date:  2009-06-26       Impact factor: 5.594

3.  The early clinical phenotype of Fabry disease: a study on 35 European children and adolescents.

Authors:  Markus Ries; Uma Ramaswami; Rossella Parini; Bengt Lindblad; Catharina Whybra; Ingrid Willers; Andreas Gal; Michael Beck
Journal:  Eur J Pediatr       Date:  2003-09-20       Impact factor: 3.183

Review 4.  Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel.

Authors:  Alessandro P Burlina; Katherine B Sims; Juan M Politei; Gary J Bennett; Ralf Baron; Claudia Sommer; Anette Torvin Møller; Max J Hilz
Journal:  BMC Neurol       Date:  2011-05-27       Impact factor: 2.474

5.  Sudoscan as a noninvasive tool to assess sudomotor dysfunction in patients with Fabry disease: results from a case-control study.

Authors:  Pauline Sahuc; Laurent Chiche; Bertrand Dussol; Jean Pouget; Jérôme Franques
Journal:  Ther Clin Risk Manag       Date:  2016-02-02       Impact factor: 2.423

6.  Skin Globotriaosylceramide 3 Load Is Increased in Men with Advanced Fabry Disease.

Authors:  Nurcan Üçeyler; Nils Schröter; Waldemar Kafke; Daniela Kramer; Christoph Wanner; Frank Weidemann; Claudia Sommer
Journal:  PLoS One       Date:  2016-11-16       Impact factor: 3.240

7.  Fabry disease in children and the effects of enzyme replacement treatment.

Authors:  Guillem Pintos-Morell; Michael Beck
Journal:  Eur J Pediatr       Date:  2009-02-26       Impact factor: 3.183

Review 8.  Anderson-Fabry Disease: From Endothelial Dysfunction to Emerging Therapies.

Authors:  Cosimo A Stamerra; Rita Del Pinto; Paolo di Giosia; Claudio Ferri; Amirhossein Sahebkar
Journal:  Adv Pharmacol Pharm Sci       Date:  2021-05-13

9.  Wilson protein expression, copper excretion and sweat production in sweat glands of Wilson disease patients and controls.

Authors:  Mark Schaefer; Mavi Schellenberg; Uta Merle; Karl Heinz Weiss; Wolfgang Stremmel
Journal:  BMC Gastroenterol       Date:  2008-07-17       Impact factor: 3.067

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.